What’s Going On With AMC Entertainment Stock?

AMC Entertainment Holdings, Inc. (NYSE: AMC) shares are trading higher Monday, though the stock remains down by more than 33% over the past month.<

AMC Entertainment Holdings, Inc. (NYSE:AMC) shares are trading higher Monday, though the stock remains down by more than 33% over the past month.

What To Know:

“Renaissance: A Film by Beyoncé,” the concert film recorded during the artist’s tour, brought in $22 million since its Friday opening, according to BoxOfficeMojo.

The concert film opened in roughly 2,500 theaters through an exclusive distribution deal with AMC Theatres and was the biggest December box office opening in years. For comparison, the Taylor Swift concert film had an opening of $92.8 million.

AMC Entertainment, one of the original “meme stocks”,  has attracted interest from short-sellers with 11.53% of available AMC shares being sold short, according to data from Benzinga Pro.

According to data from Benzinga Pro, shares of AMC are trading below the stock’s 50-day moving average of $8.66 and far below its 52-week high of $91.45.

Related News: What’s Going On With Palantir Technologies Stock?

AMC Price Action: According to Benzinga Pro, AMC Entertainment shares are up by 4% at $7.14 at the time of publication.

Image: dlsd cgl from Pixabay

Total
0
Shares
Related Posts
Read More

Tenax Therapeutics Achieves Major Milestone As USPTO Grants Notice Of Allowance For U.S. Patent Application Covering Use Of Oral Levosimendan In Pulmonary Hypertension With Heart Failure With Preserved Ejection Fraction

Once granted, this patent will provide intellectual property protection until December 2040, and may qualify for additional U.S. patent term extension beyond 2040 There are currently no FDA approved treatments for PH-HFpEF, a condition affecting more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030

TENX